Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
According to Mercks financial report, Keytrudas Q1 2025 sales reached $7.21 billion, up 4% year-over-year, but with a quarter-over-quarter decline for the first time
The data is from a phase three clinical trial funded by Eli Lilly and included nearly 1,700 people with diabetes
The second is using Xultophy, the fixed-ratio combination product containing insulin degludec and liraglutide in a single pen
A close look at CivicSciences ongoing data collection of QSRs shows that GLP-1 users are more likely to frequent some restaurants more than others
US$ 22.75
US$ 23.93
US$ 28.69
US$ 21.75
